CytomX Therapeutics Inc. (CTMX) Declined -7.26% or -1.2 To Price $15.27 On Friday


CytomX Therapeutics Inc. (CTMX) declined -7.26% or -1.2 to $15.27. It is nearly 120254 shares traded, which is 31.13% compare to the average total volume 386336. The market cap of CTMX is $686.37 million. The year to date change is -31.62%. The 52 week price range is from $15.1 to $35.0. Price of CTMX have changed 4.24% during last week. It have changed -12.77% over last month, -33.17% over last 3 months, -40.53% over last 6 months and -17.74% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 19.94. It is 30.58% above current price. The 200-day Moving Averages for CTMX is 25.00. It is 63.72% above current price. The 52-week High is 35.0. It is 129.21% from the current price. The 52-week Low is 15.1. It is -1.11% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 6.65 on 2018-09-28. Short % to float is 6.27%. There are some statistics of CTMX. It is has market cap $686.37 million. The share outstanding is 44.96 million. The average volume is 386336. The revenue is 24.14M. The percent of top 15 Institution holding is 80.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -81.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -10.47%.


Tags:

Share this post